NO20044050L - Fremgangsmate for syntese av chirale N-aryl-piperaziner - Google Patents

Fremgangsmate for syntese av chirale N-aryl-piperaziner

Info

Publication number
NO20044050L
NO20044050L NO20044050A NO20044050A NO20044050L NO 20044050 L NO20044050 L NO 20044050L NO 20044050 A NO20044050 A NO 20044050A NO 20044050 A NO20044050 A NO 20044050A NO 20044050 L NO20044050 L NO 20044050L
Authority
NO
Norway
Prior art keywords
piperazines
chiral
aryl
synthesis
Prior art date
Application number
NO20044050A
Other languages
English (en)
Norwegian (no)
Inventor
Gregg Brian Feigelson
Joseph Zeldis
Ivo Jirkovsky
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20044050L publication Critical patent/NO20044050L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO20044050A 2002-03-12 2004-09-24 Fremgangsmate for syntese av chirale N-aryl-piperaziner NO20044050L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36343102P 2002-03-12 2002-03-12
PCT/US2003/007078 WO2003078417A1 (en) 2002-03-12 2003-03-10 Process for synthesizing chiral n-aryl piperazines

Publications (1)

Publication Number Publication Date
NO20044050L true NO20044050L (no) 2004-09-24

Family

ID=28041762

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044050A NO20044050L (no) 2002-03-12 2004-09-24 Fremgangsmate for syntese av chirale N-aryl-piperaziner

Country Status (23)

Country Link
US (1) US6713626B2 (de)
EP (1) EP1483255B1 (de)
JP (1) JP4391241B2 (de)
KR (1) KR20040105765A (de)
CN (2) CN1982307A (de)
AR (1) AR038930A1 (de)
AT (1) ATE439356T1 (de)
AU (1) AU2003220094B2 (de)
BR (1) BR0308377A (de)
CA (1) CA2477892C (de)
CR (1) CR7431A (de)
DE (1) DE60328756D1 (de)
EC (1) ECSP045290A (de)
ES (1) ES2329122T3 (de)
IL (1) IL163827A0 (de)
MX (1) MXPA04008729A (de)
NO (1) NO20044050L (de)
NZ (1) NZ535168A (de)
RU (1) RU2315762C2 (de)
TW (1) TW200403231A (de)
UA (1) UA79273C2 (de)
WO (1) WO2003078417A1 (de)
ZA (1) ZA200408202B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060287335A1 (en) * 2000-11-28 2006-12-21 Wyeth Serotonergic agents for treating sexual dysfunction
US20060223824A1 (en) * 2000-11-28 2006-10-05 Wyeth Serotonergic agents
DK1408976T5 (da) 2001-07-20 2011-01-10 Psychogenics Inc Behandling af ADHD (Attention deficit hyperactivity disorder)
US7361773B2 (en) * 2002-03-12 2008-04-22 Wyeth Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
US7091349B2 (en) * 2002-03-12 2006-08-15 Wyeth Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution
TWI288642B (en) * 2002-03-12 2007-10-21 Wyeth Corp Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
JP2005527530A (ja) * 2002-03-12 2005-09-15 ワイス キラル１，４−二置換ピペラジン
US20070099931A1 (en) * 2004-03-19 2007-05-03 Wyeth Pharmaceutical dosage forms and compositions
US20050209245A1 (en) * 2004-03-19 2005-09-22 Wyeth Process for preparing N-aryl-piperazine derivatives
US20050215561A1 (en) * 2004-03-19 2005-09-29 Krishnendu Ghosh Pharmaceutical dosage forms and compositions
BRPI0609370A2 (pt) * 2005-03-01 2010-03-30 Wyeth Corp cloridrato de 4-ciano-n-{(2r)-2-[4-(2,3-dihidro-benzo[1,4]dioxin-5-il)-pip erazin-1-il]-propil}-n-piridin-2-il-benzamida cristalino e amorfo
CN117003693B (zh) * 2022-05-05 2026-01-30 四川大学华西医院 一类哌啶衍生物及其制备方法和用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3586794T2 (de) 1984-12-21 1993-05-27 Duphar Int Res Arzneimittel mit psychotroper wirkung.
JPH01125357A (ja) 1987-11-06 1989-05-17 Dainippon Pharmaceut Co Ltd トリペプチドの誘導体
AU645681B2 (en) * 1991-05-02 1994-01-20 John Wyeth & Brother Limited Piperazine derivatives
GB9125900D0 (en) * 1991-12-05 1992-02-05 Wyeth John & Brother Ltd Piperazine derivatives
WO1994024115A1 (fr) * 1993-04-16 1994-10-27 Santen Pharmaceutical Co., Ltd. Nouveau derive de piperazine
GB9411099D0 (en) * 1994-06-03 1994-07-27 Wyeth John & Brother Ltd Piperazine derivatives
DK0763024T3 (da) 1994-06-03 2002-12-02 Wyeth John & Brother Ltd Fremgangmåde og mellemprodukter til fremstilling af piperazinderivater
GB9413772D0 (en) * 1994-07-08 1994-08-24 Wyeth John & Brother Ltd 5-HT1A ligands
GB9514901D0 (en) * 1995-07-20 1995-09-20 American Home Prod Piperazine derivatives
WO1997037655A1 (en) 1996-04-10 1997-10-16 Merck & Co., Inc. αvβ3 ANTAGONISTS
US6469007B2 (en) 2000-11-28 2002-10-22 Wyeth Serotonergic agents

Also Published As

Publication number Publication date
TW200403231A (en) 2004-03-01
NZ535168A (en) 2006-03-31
CN1982307A (zh) 2007-06-20
BR0308377A (pt) 2005-01-11
IL163827A0 (en) 2005-12-18
RU2004130300A (ru) 2005-04-10
ATE439356T1 (de) 2009-08-15
UA79273C2 (en) 2007-06-11
AU2003220094A1 (en) 2003-09-29
JP4391241B2 (ja) 2009-12-24
EP1483255A1 (de) 2004-12-08
US20030187265A1 (en) 2003-10-02
AR038930A1 (es) 2005-02-02
KR20040105765A (ko) 2004-12-16
ECSP045290A (es) 2004-10-26
CA2477892A1 (en) 2003-09-25
RU2315762C2 (ru) 2008-01-27
EP1483255B1 (de) 2009-08-12
ZA200408202B (en) 2007-03-28
US6713626B2 (en) 2004-03-30
JP2005526775A (ja) 2005-09-08
CR7431A (es) 2008-07-29
ES2329122T3 (es) 2009-11-23
DE60328756D1 (de) 2009-09-24
MXPA04008729A (es) 2005-07-13
CN1304388C (zh) 2007-03-14
CA2477892C (en) 2010-11-23
AU2003220094B2 (en) 2009-04-23
CN1642936A (zh) 2005-07-20
WO2003078417A1 (en) 2003-09-25

Similar Documents

Publication Publication Date Title
NO20043345L (no) Fremgangsmate for fremstilling av hydrokarboner
NO20034285D0 (no) Fremgangsmåte for fremstilling av syntesegass
NO20053796D0 (no) Process for the production of particles
NO20043586L (no) Fremgangsmate for fremstilling av organiske forbindelser
NO20044050L (no) Fremgangsmate for syntese av chirale N-aryl-piperaziner
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
NO20041182L (no) Fremgangsmate for fremstilling av silisium
NO20033408D0 (no) Fremgangsmåte for fremstilling av krystallinske nanopartikler
NO20041850L (no) Fremgangsmate for dannelse av profenkrystaller
IS2590B (is) Aðferð til nýmyndunar á bensímídasólefnasambandi
HRP20050360A2 (en) Novel method for the industrial synthesis of the m
NO20041224L (no) Fremgangsmate for fremstilling av hydrokarboner
NO20034597D0 (no) Fremgangsmåte for fremstilling av cantaxantin
NO20043760L (no) Fremgangsmate til fremstilling av olefiner
ITMI20020933A0 (it) Procedimento per la sintesi di clopidogrel
NO20043988L (no) Fremgangsmate for fremstilling av chirale 1,4-substituerte piperaziner
NO20050885L (no) Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
ZA200602149B (en) Process for the synthesis of 6-amino-4-[(3-chloro-4-fluo-rophenyl)amino]-7-ethoxy-quinoline-3-carbonitrile
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
EP1813596A4 (de) Verfahren zu herstellung von alpha, alpha-difluoramin
AU2003242867A8 (en) Process for the synthesis of mosapride
EG24122A (en) Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolines
NO20052392L (no) Fremgangsmate for fremstilling av acetylenforbindelser.
AU2003270143A8 (en) Improved methods for the synthesis of nucleic acids
EP1548017A4 (de) Verfahren zur herstellung organischer verbindungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application